Growth Metrics

Inspire Medical Systems (INSP) Depreciation & Amortization (CF) (2017 - 2026)

Inspire Medical Systems' Depreciation & Amortization (CF) history spans 10 years, with the latest figure at $5.1 million for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 67.87% to $5.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $16.0 million, a 83.02% increase, with the full-year FY2025 number at $14.0 million, up 113.08% from a year prior.
  • Depreciation & Amortization (CF) hit $5.1 million in Q1 2026 for Inspire Medical Systems, up from $3.8 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for INSP hit a ceiling of $5.1 million in Q1 2026 and a floor of $359000.0 in Q1 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $1.8 million across 5 years, with a median of $839000.0 in 2024.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 37.17% in 2022 and later soared 262.81% in 2025.
  • Tracing INSP's Depreciation & Amortization (CF) over 5 years: stood at $569000.0 in 2022, then surged by 43.59% to $817000.0 in 2023, then skyrocketed by 203.3% to $2.5 million in 2024, then surged by 54.24% to $3.8 million in 2025, then surged by 33.7% to $5.1 million in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for INSP at $5.1 million in Q1 2026, $3.8 million in Q4 2025, and $3.7 million in Q3 2025.